R. Palin

发表

Identification of potent, soluble, and orally active TRPV1 antagonists.

Peter Littlewood, J. Maclean, O. Nimz, 2011, Bioorganic & medicinal chemistry letters.

Discovery of potent, soluble and orally active TRPV1 antagonists. Structure-activity relationships of a series of isoxazoles.

M. Ohlmeyer, Peter Littlewood, J. Maclean, 2011, Bioorganic & medicinal chemistry letters.

Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure-activity relationships.

A. Bom, D. Rees, G. Rosair, 2002, Journal of medicinal chemistry.

NMR spectra and dynamics of the sodium salt of per(6‐thiobenzoic acid)‐γ‐cyclodextrin

D. Uhrín, K. Cameron, L. Fielding, 2005 .

Structure-activity relationships and CoMFA of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic properties.

G. Wishart, P. Jones, R. Palin, 2008, Bioorganic & medicinal chemistry.

Mutual induced fit in cyclodextrin-rocuronium complexes.

J. Mestres, A. Cooper, M. Nutley, 2005, Organic & biomolecular chemistry.

Structure-activity studies of a novel series of isoxazole-3-carboxamide derivatives as TRPV1 antagonists.

M. Ohlmeyer, J. Maclean, Koc-Kan Ho, 2011, Bioorganic & medicinal chemistry letters.

A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host.

Mark Bradley, J. van Egmond, M. Bradley, 2002, Angewandte Chemie.

Synthesis and evaluation of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic and sedative properties.

Mark A. Weston, A. Bom, G. Wishart, 2007, Bioorganic & medicinal chemistry.

Asymmetric synthesis of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one derivatives, potent and selective NOP agonists

Mark A. Weston, G. Rosair, P. Jones, 2008 .

Synthesis and SAR studies of 3-phenoxypropyl piperidine analogues as ORL1 (NOP) receptor agonists.

Mark A. Weston, R. Morphy, G. Wishart, 2005, Bioorganic & medicinal chemistry letters.

Mono-6-(O-2,4,6-triisopropylbenzenesulfonyl)-γ-cyclodextrin, a novel intermediate for the synthesis of mono-functionalised γ-cyclodextrins

Zhang Mingqiang, R. Palin, Alan B. Prosser, 2001 .

Novel piperidinium and pyridinium agents as water-soluble acetylcholinesterase inhibitors for the reversal of neuromuscular blockade.

P. Cowley, Mingqiang Zhang, R. Palin, 2002, Bioorganic & medicinal chemistry letters.

Modified gamma-cyclodextrins and their rocuronium complexes.

A. Cooper, K. Cameron, L. Fielding, 2002, Organic letters.

New approaches to reversal of neuromuscular block.

A. Bom, R. Palin, J. Clark, 2002, Current opinion in drug discovery & development.

Chemical chelation as a novel method of NMB reversal - discovery of Org 25969: 16

A. Bom, D. Rees, K. Cameron, 2001 .

Quaternary salts of E2020 analogues as acetylcholinesterase inhibitors for the reversal of neuromuscular block.

P. Cowley, Mingqiang Zhang, R. Palin, 2002, Bioorganic & medicinal chemistry letters.

The Hypnotic, Electroencephalographic, and Antinociceptive Properties of Nonpeptide ORL1 Receptor Agonists After Intravenous Injection in Rodents

P. Jones, R. Palin, A. Byford, 2007, Anesthesia and analgesia.

Rapid access towards follow-up NOP receptor agonists using a knowledge based approach.

Mark A. Weston, D. Fletcher, G. Wishart, 2009, Bioorganic & medicinal chemistry letters.

The discovery of novel indole-2-carboxamides as cannabinoid CB(1) receptor antagonists.

M. Deehan, G. Wishart, R. Goodwin, 2011, Bioorganic & medicinal chemistry letters.